Literature DB >> 8478718

Radiation dose estimates for the carbon-14-labeled urea breath test.

J B Stubbs1, B J Marshall.   

Abstract

The use of the 14C-urea breath test for diagnosis of Helicobacter pylori infection in gastric mucosa has gained widespread acceptance and utilization. In order to obtain regulatory approval for this procedure, new dose estimates were required. Previous radiation dose equivalent estimates for males only were based upon data published in 1975 for bicarbonate metabolism. Since that time, calculational techniques for dose estimation have been significantly improved and the organ masses of Reference Man updated. We have calculated dose estimates for males and females who test positive (HP+) and negative (HP-) for gastric H. pylori infection. Our results indicate that the urinary bladder wall receives the highest absorbed dose in all four of the above subject populations (HP- males = 0.14 mGy/MBq; HP- females = 0.19 mGy/MBq; HP+ males = 0.10 mGy/MBq; HP+ females = 0.14 mGy/MBq). Gonadal absorbed doses were similar to those previously estimated (testes < 0.065 mGy/MBq and ovaries < 0.084 mGy/MBq, respectively).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478718

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

Review 1.  Safety of 14C-UBT for diagnosis of Helicobacter pylori infection in pregnancy.

Authors:  Yedidia Bentur; Doreen Matsui; Gideon Koren
Journal:  Can Fam Physician       Date:  2009-05       Impact factor: 3.275

2.  Serology and urea breath test in the diagnosis of H. pylori infection.

Authors:  P R Hawtin
Journal:  Mol Biotechnol       Date:  1999-02       Impact factor: 2.695

3.  New noninvasive tests for Helicobacter pylori gastritis. Comparison with tissue-based gold standard.

Authors:  D O Faigel; M Childs; E E Furth; A Alavi; D C Metz
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

4.  Validity and cost comparison of 14carbon urea breath test for diagnosis of H Pylori in dyspeptic patients.

Authors:  Shahid Rasool; Shahab Abid; Wasim Jafri
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

Review 5.  Helicobacter pylori.

Authors:  B E Dunn; H Cohen; M J Blaser
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

6.  A new, practical, low-dose 14C-urea breath test for the diagnosis of Helicobacter pylori infection: clinical validation and comparison with the standard method.

Authors:  Emel Oztürk; Zeki Yeşilova; Seyfettin Ilgan; Nuri Arslan; Ahmet Erdil; Bülent Celasun; Mehmet Ozgüven; Kemal Dağalp; Onder Ovali; Hikmet Bayhan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-05       Impact factor: 9.236

7.  Clinical Validation of an Office-Based C-UBT (Heliprobe) for H. pylori Diagnosis in Iranian Dyspeptic Patients.

Authors:  Fariborz Mansour-Ghanaei; Omid Sanaei; Farahnaz Joukar
Journal:  Gastroenterol Res Pract       Date:  2011-06-22       Impact factor: 2.260

8.  A re-testing range is recommended for 13C- and 14C-urea breath tests for Helicobacter pylori infection in China.

Authors:  Xiangyu Wang; Shuzhen Zhang; Eng Guan Chua; Yongsheng He; Xiaofeng Li; Aijun Liu; Haiting Chen; Michael J Wise; Barry J Marshall; Dayong Sun; Xuehong Li; Chin Yen Tay
Journal:  Gut Pathog       Date:  2021-06-12       Impact factor: 4.181

9.  The utilization of a new immunochromatographic test in detection of Helicobacter pylori antibody from maternal and umbilical cord serum.

Authors:  Fu-Chen Kuo; Chien-Yi Wu; Chao-Hung Kuo; Chia-Fang Wu; Chien-Yu Lu; Yen-Hsu Chen; Chiao-Yun Chen; Yi-Ching Lo; Ming-Tsang Wu; Huang-Ming Hu
Journal:  Biomed Res Int       Date:  2014-08-07       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.